IP Verse

Liposomes Having Useful N:P Ratio For Delivery Of Rna Molecules

Patent No. EP2729126 (titled "Liposomes Having Useful N:P Ratio For Delivery Of Rna Molecules") was filed by Glaxosmithkline on Jul 6, 2012. The application was issued on Dec 23, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACUITAS THERAPEUTICSSep 23, 2021VOSSIUS & PARTNER
ACUITAS THERAPEUTICSSep 23, 2021VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
MARGARET DIXONSep 23, 2021MEWBURN ELLIS
MULLERSep 23, 2021MULLER
WEICKMANN & WEICKMANNSep 23, 2021WEICKMANN & WEICKMANN PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2729126

GLAXOSMITHKLINE
Application Number
EP12738679A
Filing Date
Jul 6, 2012
Status
Revoked
Sep 5, 2025
Publication Date
Dec 23, 2020
External Links
Slate, Register , Google Patents